We offer integrated development and manufacturing services across the antibody drug conjugate components: antibodies, payloads, bioconjugation and sterile fill and finish. This integrated capability for the development and manufacture of antibody drug conjugate products accelerates program timelines and reduces program complexity, resource requirements and risk.
We operate GMP production suites for gram-scale ADC payload production and multi-kilogram-scale production capacity at our site in Visp, Switzerland. End-to-end service programs can be readily arranged to meet your program needs. Key aspects of our ADC payload service offer include:
Customers can utilize our unique infrastructure for ADC payloads and overall ADC capabilities to avoid extra investment in expertise, assets and infrastructure.